The burden of chronic pain for patients with osteoarthritis in Germany: a retrospective cohort study of claims data

BMC Musculoskeletal Disorders

Ursula von Schenck¹  Sigurd Prieur¹  Marie Schild²  Robert Miller³  Ulrike Müller⁴ 

[1] Elsevier Health Analytics, Berlin, Germany;Pfizer Germany GmbH, Berlin, Germany;Pfizer Germany GmbH, Berlin, Germany;Pfizer Pharma GmbH, Linkstr. 10, 10785, Berlin, Germany;Pfizer Pharma GmbH, Linkstr. 10, 10785, Berlin, Germany;

关键词: Health insurance;    Health care costs;    Cost of illness;    Direct service costs;    Sick leave;   

DOI  :  10.1186/s12891-021-04180-1

来源: Springer

【 摘 要 】

BackgroundOsteoarthritis (OA) is a common condition that is often associated with chronic pain. Pain often leads patients to seek healthcare advice and treatment. In this retrospective cohort analysis of German longitudinal healthcare claims data, we aimed to explore the healthcare resource utilisation (HRU) and related healthcare costs for patients with OA who develop chronic pain.MethodsPatient-level data was extracted from the German Institut für Angewandte Gesundheitsforschung (InGef) database. Insured persons (≥18 years) were indexed between January 2015 and December 2017 with a recent (none in the last 2 years) diagnosis of OA. HRU and costs were compared between patients categorised as with (identified via diagnosis or opioid prescription) and without chronic pain. Unweighted HRU (outpatient physician contacts, hospitalisations, prescriptions for physical therapy or psychotherapy, and incapacity to work) and healthcare costs (medication, medical aid/remedy, psychotherapy, inpatient and outpatient and sick pay in Euros [quartile 1, quartile 3]) were calculated per patient for the year following index. Due to potential demographic and comorbidity differences between the groups, inverse probability of treatment weighting (IPTW) was used to estimate weighted costs and rate ratio (RR; 95% confidence interval) of HRU by negative binomial regression modelling.ResultsOf 4,932,543 individuals sampled, 238,306 patients with OA were included in the analysis: 80,055 (34%) categorised as having chronic pain (24,463 via opioid prescription) and 158,251 (66%) categorised as not having chronic pain. The chronic pain cohort was slightly older, more likely to be female, and had more comorbidities. During the year following index, unweighted and IPTW-weighted HRU risk and healthcare costs were higher in patients with chronic pain vs those without for all categories. This led to a substantially higher total annual healthcare cost ─ observed mean; €6801 (1439, 8153) vs €3682 (791, 3787); estimated RR = 1.51 (1.36, 1.66).ConclusionsGerman patients with chronic pain and OA have higher healthcare costs and HRU than those with OA alone. Our findings suggest the need for better prevention and treatment of OA in order to reduce the incidence of chronic pain, and the resultant increase in disease burden experienced by patients.

【 授权许可】

CC BY